Lokesh Prasad new CEO of Conduent India
A leading business process services provider, Conduent India has appointed Lokesh Prasad as the new CEO of the company. In his new role, he would be creating India focused strategy and driving new internal policies, and also streamlining the organization through centralization of functions.
Prior to this, Prasad has worked as Head of Emerging Markets for UnitedHealth Group in Gurgaon, India, and was responsible for managing profit and loss (P&L) for India and the Middle East. During his tenure, he was successful in creating global source and delivery strategy for UnitedHealth Group. He was also instrumental in setting up their IT and BPO business in the US and Asia. Also, he has a decade experience of working with Infosys Technologies Limited.
On his appointment Prasad said, “The already impressive expertise of Conduent’s leadership, employees and scientists really drew me to the company. Conduent India isn’t just a regular BPO – it’s a technology hub for the entire business and builds wide-ranging solutions from transaction processing for healthcare and insurance, to cloud transformations for all kinds of business assets.”
As CEO, Prasad will further develop the $6.5 billion company’s presence in India and will grow the 10,000-employee workforce across six cities, including Bangalore, Kochi, Gurgaon, Noida, Indore and Chennai.
Ashok Vemuri, CEO of Conduent , says , “Lokesh’s background as a high-tech business developer will help Conduent India push the envelope of tech-led business services and expand its already impressive workforce. Under his direction, Conduent India will bring even more focused expertise around automation, analytics and innovative technologies to help clients progress their own digital transformation agenda.”
Conduent is a leading provider of diversified business process services with capabilities in transaction processing, automation, analytics and constituent experience and Conduent India harnesses a global network of specialized skills, technology and research.